Cogent Biosciences, Inc.

Cogent Biosciences, Inc. Estimates – NASDAQ:COGT
TradingView · 23 Oct 2026
Cogent Biosciences (COGT) Nears Three FDA Decisions. What Is Its Pipeline Worth?
Insider Monkey · 20 Oct 2026
Did FDA Filings Just Shift Cogent Biosciences Stock Investment Narrative?
Simply Wall Street · 18 Oct 2026
Here’s How Much You Would Have Made Owning Cogent Biosciences Stock In The Last 5 Years
Benzinga · 12 Oct 2026
$1000 Invested In Cogent Biosciences 5 Years Ago Would Be Worth This Much Today
Benzinga · 02 Oct 2026
Should FDA Filing Acceptance Require Action From Cogent Biosciences (COGT) Investors?
Simply Wall Street · 26 Sep 2026
3 Reasons Cogent Biosciences (COGT) Valuation Looks Pricey Following FDA NDA Acceptance
Simply Wall Street · 24 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.